Literature DB >> 2736743

The coherence spectrum. A quantitative discriminator of fibrillatory and nonfibrillatory cardiac rhythms.

K M Ropella1, A V Sahakian, J M Baerman, S Swiryn.   

Abstract

Previous work has suggested that a comparison of electrograms from two or more sites may best differentiate fibrillatory from nonfibrillatory rhythms. The coherence spectrum is a measure by which two signals may be compared quantitatively in the frequency domain. In the present study, the coherence spectrum was used to quantify the relation between spectral components of electrograms from two sites in either the atrium or ventricle during both fibrillatory and nonfibrillatory rhythms. Bipolar recordings of 35 rhythms from 20 patients were analyzed for coherence in the 1-59 Hz band. The 17 nonfibrillatory rhythms were sinus rhythm (six), paroxysmal supraventricular tachycardia (two), atrial flutter (four), and monomorphic ventricular tachycardia (five). The 18 fibrillatory rhythms were atrial fibrillation (12) and ventricular fibrillation (six). Nonfibrillatory rhythms exhibited moderate-to-high levels of coherence throughout the 1-59 Hz band, with peaks concentrated at the rhythm's fundamental frequency and its harmonics. Fibrillatory rhythms exhibited little coherence throughout the 1-59 Hz band, and harmonics were not evident. The mean magnitude-squared coherence (scale of 0 to 1) for the 1-59 Hz band ranged from 0.22 to 0.86 (mean +/- SD, 0.52 +/- 0.19) for nonfibrillatory rhythms and from 0.042 to 0.12 (0.067 +/- 0.021) for fibrillatory rhythms. Separation of fibrillatory and nonfibrillatory rhythms was possible whether signals were recorded by floating or fixed-electrode configurations. These findings indicate that comparison of two electrograms with magnitude-squared coherence measurements differentiates fibrillatory from nonfibrillatory rhythms. A recognition algorithm based on coherence spectra may provide a major variations in lead configuration.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2736743     DOI: 10.1161/01.cir.80.1.112

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  Ventricular remodelling after myocardial infarction.

Authors:  M A Vannan; D J Taylor
Journal:  Br Heart J       Date:  1992-09

Review 2.  Atrial fibrillation: defining potential curative ablation targets.

Authors:  D G Benditt; N Samniah; G J Fahy; K G Lurie; S Sakaguchi
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

3.  Complex dynamics underlying the human electrocardiogram.

Authors:  F Ravelli; R Antolini
Journal:  Biol Cybern       Date:  1992       Impact factor: 2.086

4.  Azimilide decreases defibrillation voltage requirements and increases spatial organization during ventricular fibrillation.

Authors:  X Q Qi; D Newman; P Dorian
Journal:  J Interv Card Electrophysiol       Date:  1999-03       Impact factor: 1.900

Review 5.  Current approaches and future developments in automatic tachycardia detection and diagnosis.

Authors:  P S Astridge; G C Kaye; E J Perrins
Journal:  Br Heart J       Date:  1993-08

6.  Measure of synchronisation of right atrial depolarisation wavefronts during atrial fibrillation.

Authors:  V Barbaro; P Bartolini; G Calcagnini; F Censi; A Michelucci
Journal:  Med Biol Eng Comput       Date:  2002-01       Impact factor: 2.602

7.  Atrial fibrillation organization: quantification of propofol effects.

Authors:  Raquel Cervigón; Javier Moreno; César Sánchez; Richard B Reilly; Julián Villacastín; José Millet; Francisco Castells
Journal:  Med Biol Eng Comput       Date:  2008-11-19       Impact factor: 2.602

8.  Principal component analysis and cluster analysis for measuring the local organisation of human atrial fibrillation.

Authors:  L Faes; G Nollo; M Kirchner; E Olivetti; F Gaita; R Riccardi; R Antolini
Journal:  Med Biol Eng Comput       Date:  2001-11       Impact factor: 3.079

9.  Spatio-temporal Organization During Ventricular Fibrillation in the Human Heart.

Authors:  Jinny Robson; Parham Aram; Martyn P Nash; Chris P Bradley; Martin Hayward; David J Paterson; Peter Taggart; Richard H Clayton; Visakan Kadirkamanathan
Journal:  Ann Biomed Eng       Date:  2018-03-15       Impact factor: 3.934

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.